Abstract
The prevalence of type 2 diabetes mellitus (T2DM) continues to rise swiftly, while the disease represents an important risk factor for morbidity and mortality due to cardiovascular disease. The investigation of non-conventional cardiovascular risk factors such as low adiponectin levels is crucial in order to promote new approaches to the treatment of such individuals. Clinical studies tha…